Date: 2026-02-22 | GauchoRico | First look — no prior GR corpus on CRDO
Holy smokes!! Credo Technology just delivered the largest beat in its public company history — $406M preliminary vs. a 340Mguidemidpoint, a1963-68M in a single quarter. FY26 implied revenue crossed $1.3B and the company raised full-year guidance to >200% growth. This is not a normal quarter for a semiconductor business.
That said, this is a preliminary release. The full earnings call is March 2, 2026. There is one open question so alarming that it could change the thesis: a non-GAAP gross margin guide of ~45% against a GAAP GM of 67.5%. Until that contradiction is resolved, I am treating this as a conditional buy.
Atlas scored CRDO at conviction 4/5 with a six-factor rating that I largely agree with. Atlas correctly identified the GM discrepancy as "the critical question for March 2." It weighted the 5-consecutive-beat pattern over the literal Q4 sequential guide (mid-single digits), which I think is right — management has been systematically under-promising by 15-20%+ for five straight quarters. The bear case Atlas flagged — customer concentration and AI capex cycle dependency — are real, but concentration is improving (2 → 4 customers >10%). I agree with the 4/5 conviction. My own read adds more weight to the gross margin question and the LEAPS opportunity if the March 2 call clears it up.
| | Q4_FY23 | Q1_FY24 | Q2_FY24 | Q3_FY24 | Q4_FY24 | Q1_FY25 | | | Apr-23 | Jul-23 | Oct-23 | Jan-24 | Apr-24 | Jul-24 | |---|---|---|---|---|---|---| | Revenue ($m) | 32.1 | 35.1 | 44.0 | 46.6* | 60.8* | 59.7 | | QoQ % | -40.9% | +9.4% | +25.4% | +5.7% | +30.5% | -1.8% | | YoY % | -14.4% | -24.5% | -14.4% | — | +30.5% | +70.1% | | GAAP GM % | — | — | — | — | — | — | | GAAP Op Margin % | — | — | — | — | — | — |
| | Q2_FY25 | Q3_FY25 | Q4_FY25 | Q1_FY26 | Q2_FY26 | Q3_FY26 | | | Oct-24 | Jan-25 | Apr-25 | Jul-25 | Oct-25 | Jan-26 | |---|---|---|---|---|---|---| | Revenue ($m) | 72.0 | 135.0 | 170.0 | 223.1 | 268.0 | 406.0* | | QoQ % | +20.6% | +87.5% | +25.9% | +31.2% | +20.1% | +51.5% | | YoY % | +63.6% | +154.2% | +179.6% | +273.7% | +272.2% | +201.5% | | GAAP GM % | — | — | 67.4% | 67.4% | 67.5% | N/A* | | GAAP Op Margin % | — | — | 36.8% | 27.2% | 29.4% | N/A* | | FCF Margin % | — | — | 31.9% | 23.0% | — | — |
*Q3_FY26 preliminary — margins not yet reported. Full results March 2, 2026. *Q3/Q4 FY24 estimates from scout — treat as approximate.
Beat History (last 5 quarters): | Quarter | Guide Midpoint | Actual | Beat $ | Beat % | |---|---|---|---|---| | Q3_FY25 | $60M | 135M|+75M | +125% | | Q4_FY25 | $190M | 170M|−20M | -10.5% (MISS) | | Q1_FY26 | $180M | 223M|+43M | +23.9% | | Q2_FY26 | $210M | 268M|+58M | +27.6% | | Q3_FY26 | $340M | 406M|+66M | +19.4% |
Q4 FY25 was a miss — the only one in recent history. The 5 quarters since have all been material beats, widening in absolute dollar magnitude.
1. Growth Rate (>40% qualifying filter) 201.5% YoY. 51.5% QoQ. This is acceleration back above 200% YoY after two quarters in the 270% range. These are extraordinary numbers for a semiconductor company. The 40% bar is not just cleared — it's demolished. PASS.
2. Trajectory After the inventory correction (Q4 FY23 to Q2 FY24), CRDO has been in an almost vertical re-acceleration. Q3 FY25 was the inflection ($60M → $135M in one quarter). Every quarter since has built on it. The re-acceleration in Q3 FY26 (from +20% QoQ to +51% QoQ) is particularly interesting — demand picked up sharply late in the quarter per management. This is not a decelerating trajectory. UP.
3. Gross Margins This is where I slow down. GAAP GM has been stable at 67.4-67.5% for three consecutive quarters — very high for semiconductors, approaching software economics. That's a green light in isolation.
But the full-year FY26 non-GAAP GM guide is ~45%. That is a 22-percentage-point gap vs GAAP actuals. Non-GAAP typically EXCLUDES stock-based compensation, which would make it HIGHER than GAAP, not lower. Something is inverted here. Possibilities: (a) the ~45% refers to a different metric or was reported incorrectly; (b) product mix shifts toward lower-margin AECs are expected to compress margins dramatically in H2; (c) there is a large anticipated cost that hits non-GAAP but not GAAP (unusual). I cannot reconcile this and I will not pretend I can. This is the #1 question for March 2. CONDITIONAL — high current margins, unexplained forward warning.
4. Competitive Dominance 88% market share in Active Electrical Cables (AECs) for AI data centers. Four hyperscalers as customers, with a fifth reportedly in validation. Proprietary DSP technology with 2-year design lead per management commentary. Zero-Flap Optics, ALCs (Active Line Cards), and OmniConnect are expanding the addressable market from ~3Bto>10B. This is about as close to "no real competition" as you get in semiconductors. STRONG.
5. Relative Valuation
18x EV/TTM for a company growing 200%+ YoY with 30%+ GAAP FCF margins is not obviously expensive. My CRM Case Study benchmark: CRM was frequently at 10-15x EV/Sales at lower growth rates. CRDO's PEG equivalent is sub-0.1x. The stock has already re-rated on the prelim — so you're paying for some of the beat. RICH but justifiable at this growth rate. I wouldn't call it cheap. I'd call it fair-to-rich for what you're getting.
6. Special Circumstances The AI data center buildout is the most powerful infrastructure spending cycle I've seen since cloud build-out. Hyperscalers are spending hundreds of billions and AECs are critical connective tissue in GPU racks. CRDO's technology enables higher bandwidth at lower power vs. traditional optical — the secular tailwind is real and multi-year. PRESENT.
I want to dwell on this because it matters enormously.
GAAP GM has been 67.4%, 67.4%, 67.5% for three consecutive quarters. Stable and high. The FY26 non-GAAP GM guide is ~45%. That's a 22-point gap in the wrong direction. Standard non-GAAP adjustments (remove SBC, amortization) should push the number HIGHER than GAAP, not lower.
If the ~45% non-GAAP GM is accurate and refers to actual product-level economics going forward, the thesis changes materially. A 45% GM business trading at 18x EV/Sales is a very different animal from a 67% GM business at the same multiple. The valuation math shifts significantly.
Possible benign explanations: the ~45% was misquoted, refers to a segment or product line, or was stated in a different context (perhaps operating margin?). Possible negative explanations: AEC product margins are structurally lower and mix is shifting.
I need March 2 to resolve this. Until then, I hold but do not add.
From the preliminary press release: "Demand picked up sharply late in the quarter... strong, sustained customer demand, driven by hyperscale data centers, AI networking upgrades and wider use of Credo's connectivity products."
The language is confident and specific. "Picked up sharply late in the quarter" explains the massive beat — this wasn't linearly forecasted by management either, which also explains why the guide was set at $340M. This is a real demand surge, not a pull-forward.
FY26 guidance raised to >200% growth implies full-year revenue >1.3B.ThisisthefourthraiseofFY26guidance.Theoriginalexpectationwas 800M. That kind of guide expansion is exceptional.
Q4 guide at mid-single-digit sequential (~$425-430M) is conservative by any measure — it would be the slowest sequential growth rate in recent history after a 51% QoQ quarter. Given the 5-quarter beat pattern, I'd estimate Q4 actual in the $480-520M range. We will see what happens...
Prior (no prior GR corpus): First analysis — no prior beliefs to update.
Initial thesis formed this quarter:
This is a portfolio-worthy business if March 2 confirms 67%+ GM trajectory.
At 20.1Bmarketcapand 1.07B TTM revenue (post Q3 prelim), CRDO trades at ~18x EV/TTM Sales. With FY26 implied at ~$1.32B, that's ~14.6x forward.
Benchmarking to my CRM Case Study: Salesforce rarely traded below 10x EV/Sales during its hypergrowth phase. CRDO at 18x for 200%+ growth with 30%+ FCF margins is aggressive but not insane. The risk is that growth normalizes — but we have no evidence of that yet, and the TAM expansion to >$10B gives multiple additional growth vectors.
If the business sustains 50%+ growth into FY27 and GM holds at 65%+, FY27 revenue could reach $2.0B+ with FCF margins of 35%+. At 15x EV/FY27 Sales (compression from 18x), that's $30B+ market cap vs $20B today. That's a reasonable upside case over 18 months.
LEAPS thought: If March 2 confirms the thesis, Jan'28 calls could be very attractive on any dip toward 50.Currentstock(implied 117 from $20.1B market cap / 171.9M shares). Jan'28 $115C would be near-the-money with 2 years of runway. I will evaluate post March 2.
Prior position: None (first GR analysis of CRDO).
Action: WATCH → conditional BUY after March 2.
The business is extraordinary on every metric I care about except one unresolved question. I do not initiate positions on preliminary results when there's a material unexplained discrepancy in the margin guide. March 2 will either confirm this is a top-5 position candidate or reveal a structural margin issue that changes the calculus.
Conditions to initiate:
If all four are confirmed, CRDO becomes a 10%+ position candidate with LEAPS on dips.
| Factor | Rating | Notes |
|---|---|---|
| Revenue Growth | ★★★★★ | 201% YoY, 51% QoQ — extraordinary |
| Trajectory | ★★★★★ | Re-acceleration; demand surged late Q3 |
| Gross Margins | ★★★★☆ | 67.5% GAAP excellent; 45% non-GAAP guide unexplained |
| Competitive Dominance | ★★★★★ | 88% AEC share, 5-hyperscaler pipeline |
| Valuation | ★★★☆☆ | 18x EV/TTM fair for growth rate, but not cheap |
| Special Circumstances | ★★★★★ | AI data center capex cycle; $10B+ TAM expansion |
Overall Conviction: 4/5 — one question away from 5/5.
Next catalyst: March 2, 2026, 2:00 PM PT — full Q3 results + Q4 guide + gross margin explanation.
We will see what happens...
GR